ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "juvenile idiopathic arthritis (JIA) and patient outcomes"

  • Abstract Number: 2316 • 2017 ACR/ARHP Annual Meeting

    Barriers at School for Children with Juvenile Idiopathic Arthritis (JIA) – a Patient Reported Outcome

    Kelsey Chomistek1, Nicole Johnson1, Rebeka Stevenson1, Nadia Luca2, Paivi Miettunen1, Susanne Benseler2, Dwaraka Veeramreddy3 and Heinrike Schmeling4, 1Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, 2Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, 3University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, 4Alberta Children’s Hospital/University of Calgary, Calgary, AB, Canada

    Background/Purpose: Few studies in children with chronic illnesses/disability have reported challenges faced by patients at school. Therefore, the objective of this study is to identify…
  • Abstract Number: 2434 • 2015 ACR/ARHP Annual Meeting

    Promis Tools for Measurement of Patient-Reported Outcomes in Children with Juvenile Arthritis

    Timothy Brandon1, Brandon Becker1, Katherine Bevans1 and Pamela F. Weiss2, 1Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, 2Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose:  Child/parent perspectives on their own/their child's health are highly pertinent to disease management. PROMIS is a collection of patient-reported outcome measures that were developed…
  • Abstract Number: 2902 • 2014 ACR/ARHP Annual Meeting

    The Health Status of Patients with Juvenile Idiopathic Arthritis (JIA) Significantly Worsens after Transfer from Pediatric to Adult Care

    Kirsten Minden1, Jens Klotsche2, Martina Niewerth2, Angela Zink3 and Gerd Horneff4, 1Chidlrens´ hospital, Charité University Medicine, Berlin, Germany, 2Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, 3German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany, 4Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany

    Background/Purpose A minority of patients with polyarticular JIA enter adulthood in drug free remission. Thus, patients are in need of care beyond adolescence. There is…
  • Abstract Number: 300 • 2014 ACR/ARHP Annual Meeting

    Patient-Reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Mannequin Format

    Maryanne Dijkstra1, Janneke Anink1, Philomine A. van Pelt1,2, Johanna M.W. Hazes2 and Lisette W.A. van Suijlekom-Smit1, 1Pediatric Rheumatology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands, 2Rheumatology, Erasmus MC, Rotterdam, Netherlands

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is a common chronic disease, requiring regular monitoring. Patient-reported outcomes can assist monitoring, may promote patient self-management and can be…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology